Gerald W Crabtree - Net Worth and Insider Trading

Gerald W Crabtree Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gerald W Crabtree owns 1 companies in total, including PharmaCyte Biotech Inc (PMCB) .

Click here to see the complete history of Gerald W Crabtree’s form 4 insider trades.

Insider Ownership Summary of Gerald W Crabtree

Ticker Comapny Transaction Date Type of Owner
PMCB PharmaCyte Biotech Inc 2021-08-10 director & Chief Science Officer

Gerald W Crabtree Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gerald W Crabtree Ownership Network

Ownership Network List of Gerald W Crabtree

No Data

Ownership Network Relation of Gerald W Crabtree

Insider Network Chart

Gerald W Crabtree Owned Company Details

What does PharmaCyte Biotech Inc do?

Who are the key executives at PharmaCyte Biotech Inc?

Gerald W Crabtree is the director & Chief Science Officer of PharmaCyte Biotech Inc. Other key executives at PharmaCyte Biotech Inc include director & CFO Carlos Trujillo , director & Chairman & CEO & Pres and GC Kenneth L. Waggoner , and director & CEO Martin Schmieg .

PharmaCyte Biotech Inc (PMCB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PharmaCyte Biotech Inc (PMCB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PharmaCyte Biotech Inc (PMCB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PharmaCyte Biotech Inc (PMCB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PharmaCyte Biotech Inc Insider Transactions

No Available Data

Gerald W Crabtree Mailing Address

Above is the net worth, insider trading, and ownership report for Gerald W Crabtree. You might contact Gerald W Crabtree via mailing address: 12510 Prosperity Dr., Suite #310, Silver Spring Md 20904.

Discussions on Gerald W Crabtree

No discussions yet.